Archive | February, 2010

Sibaya Twitter Weekly Updates for 2010-02-28

NHS – Nurse HomeCare Role – BBC News – Specialist nurse role 'critical to care' http://bit.ly/aPJfON # Impact of Femoral Vascular Closure Devices– Sanborn et al. 3 (1): 57 — Circulation: Cardiovascular Interventions – http://goo.gl/VlcW # Don't worry, be happy:positive affect reduced 10-year incident coronary heart disease: Canadian Health Survey Eur Heart J http://goo.gl/QAtc # [...]

Read full storyComments { 0 }

DMLA, quatre lettres pour perdre la vue (French)

Press Release: DMLA, quatre lettres pour perdre la vue. RETINA FRANCE soutient, aide et renseigne les nombreuses personnes dans notre pays atteintes par un problème visuel. La DMLA, dégénérescence maculaire liée à l’âge, touche plus d’un million de personnes en détruisant progressivement le centre de la rétine, appelé Macula. Peu à peu la vision des [...]

Read full storyComments { 0 }

Sibaya Twitter Weekly Updates for 2010-02-21

Invacare Rolls In Value – http://goo.gl/nLBS – No Information on peers Pride and Sunrise – at least not publically # Sibaya: (More Unbridled Capitalism As) Patients Battle For Drugs In The UK http://barl.in/aboGry # Powered by Twitter Tools

Read full storyComments { 0 }

Wheelchair Costs To Rise In Europe – Early Warning

There is no doubt that with the strengthening dollar, costs for homecare products are set to rise in Europe. Most manufacturers and distributors of wheelchairs and other homecare products extensively source wheelchairs or components from China, where products are usually procured in US Dollars. A quick glance at a ten year chart will show that [...]

Read full storyComments { 0 }

(More Unbridled Capitalism As) Patients Battle For Drugs In The UK

Where does the balance between the profit motive and patient care meet? Where in the so called first world can you not go to a pharmacy and pick up the drugs you need with the minimal delay – and no, more deregulation is not the answer. BBC News – Patients miss out on treatment as [...]

Read full storyComments { 0 }